IBIS PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
IBIS PHARMA
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€561,907
2024 · €684,904-€122,997
Equity
€4.0m
2024 · €3.4m+€561,907
Cash
€1.6m
2024 · €944,999+€671,668
Balance sheet total
€5.9m
2024 · €6.6m-€669,334
Largest movements
Assets
- Receivables within one year -€1.7m
down €1.7m (-62.7%), from €2.8m to €1.0m
of which Trade receivables: -€1.7m
- Cash +€671,668
up €671,668 (+71.1%), from €944,999 to €1.6m
mainly Receivables within one year (+€1.7m) and Net result for the year (+€561,907)
- Stocks and contracts +€427,967
up €427,967 (+16.8%), from €2.6m to €3.0m
Equity and liabilities
- Other debts -€700,296
no longer reported in 2025 (was €700,296)
- Reserves +€561,907
up €561,907 (+17.5%), from €3.2m to €3.8m
of which Distributable reserves: +€561,907
- Trade debts -€535,188
down €535,188 (-23.8%), from €2.3m to €1.7m
- Accrued charges and deferred income +€86,612
up €86,612 (+109.8%), from €78,914 to €165,525
- Tax, wage and social debts -€82,369
down €82,369 (-60.5%), from €136,052 to €53,683
of which Taxes: -€82,352
Income statement
- Turnover -€944,393
down €944,393 (-5.3%), from €17.9m to €16.9m
- Goods and materials -€894,032
down €894,032 (-5.6%), from €16.0m to €15.1m
of which Purchases: -€704,736
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€684,904
Turnover
-€944,393
Other operating income
-€66,685
Goods and materials
+€894,032
Services and other goods
+€47,863
Staff costs
-€55,314
Depreciation
+€12,072
Other operating charges
-€196
Other operating items
-€26,615
Financial income
+€42,322
Financial charges
-€79,858
Taxes
+€53,775
Result 2025
€561,907
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€652,862
Investment
+€18,806
Financing
€0
Cash 2024
€944,999
From operations (derived)
+€652,862
Net result for the year
+€561,907
Depreciation
+€22,898
Stocks and contracts
-€427,967
Receivables within one year
+€1.7m
Deferred charges and accrued income
-€1,314
Trade debts
-€535,188
Tax, wage and social debts
-€82,369
Other debts
-€700,296
Accrued charges and deferred income
+€86,612
Investment (derived)
+€18,806
Investment in fixed assets (net)
+€18,806
Cash 2025
€1.6m
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €6,556,853 | €5,887,519 | -€669,334 | -10.2% |
| Fixed assets | 21/28 | €116,321 | €74,617 | -€41,704 | -35.9% |
| Tangible fixed assets | 22/27 | €116,321 | €74,617 | -€41,704 | -35.9% |
| Plant, machinery and equipment | 23 | €516 | €6,943 | +€6,426 | +1244.5% |
| Furniture and vehicles | 24 | €115,804 | €67,675 | -€48,130 | -41.6% |
| Other tangible fixed assets | 26 | €0 | €0 | = | |
| Current assets | 29/58 | €6,440,532 | €5,812,902 | -€627,630 | -9.7% |
| Stocks and contracts in progress | 3 | €2,550,926 | €2,978,893 | +€427,967 | +16.8% |
| Stocks | 30/36 | €2,550,926 | €2,978,893 | +€427,967 | +16.8% |
| Goods purchased for resale | 34 | €2,550,926 | €2,978,893 | +€427,967 | +16.8% |
| Amounts receivable within one year | 40/41 | €2,757,382 | €1,028,802 | -€1.7m | -62.7% |
| Trade receivables | 40 | €2,741,324 | €995,322 | -€1.7m | -63.7% |
| Other amounts receivable | 41 | €16,057 | €33,480 | +€17,423 | +108.5% |
| Cash at bank and in hand | 54/58 | €944,999 | €1,616,667 | +€671,668 | +71.1% |
| Deferred charges and accrued income | 490/1 | €187,225 | €188,539 | +€1,314 | +0.7% |
| Total equity and liabilities | 10/49 | €6,556,853 | €5,887,519 | -€669,334 | -10.2% |
| Equity | 10/15 | €3,389,147 | €3,951,053 | +€561,907 | +16.6% |
| Contributions | 10/11 | €174,368 | €174,368 | = | 0.0% |
| Capital | 10 | €174,368 | €174,368 | = | 0.0% |
| Issued capital | 100 | €174,368 | €174,368 | = | 0.0% |
| Reserves | 13 | €3,214,779 | €3,776,685 | +€561,907 | +17.5% |
| Non-distributable reserves | 130/1 | €17,437 | €17,437 | = | 0.0% |
| Legal reserve | 130 | €17,437 | €17,437 | = | 0.0% |
| Distributable reserves | 133 | €3,197,342 | €3,759,249 | +€561,907 | +17.6% |
| Amounts payable | 17/49 | €3,167,707 | €1,936,466 | -€1.2m | -38.9% |
| Amounts payable within one year | 42/48 | €3,088,793 | €1,770,941 | -€1.3m | -42.7% |
| Trade debts | 44 | €2,252,445 | €1,717,258 | -€535,188 | -23.8% |
| Suppliers | 440/4 | €2,252,445 | €1,717,258 | -€535,188 | -23.8% |
| Taxes, remuneration and social security | 45 | €136,052 | €53,683 | -€82,369 | -60.5% |
| Taxes | 450/3 | €82,352 | - | -€82,352 | |
| Remuneration and social security | 454/9 | €53,700 | €53,683 | -€17 | 0.0% |
| Other amounts payable | 47/48 | €700,296 | - | -€700,296 | |
| Accrued charges and deferred income | 492/3 | €78,914 | €165,525 | +€86,612 | +109.8% |
| Operating income | 70/76A | €18,049,752 | €17,042,476 | -€1.0m | -5.6% |
| Turnover | 70 | €17,858,563 | €16,914,169 | -€944,393 | -5.3% |
| Other operating income | 74 | €187,057 | €120,372 | -€66,685 | -35.6% |
| Non-recurring operating income | 76A | €4,132 | €7,934 | +€3,802 | +92.0% |
| Operating charges | 60/66A | €17,135,389 | €16,267,350 | -€868,039 | -5.1% |
| Goods for resale, raw materials and consumables | 60 | €16,003,535 | €15,109,503 | -€894,032 | -5.6% |
| Purchases | 600/8 | €16,290,047 | €15,585,311 | -€704,736 | -4.3% |
| Change in stocks: decrease (increase) | 609 | -€286,512 | -€475,808 | -€189,296 | -66.1% |
| Services and other goods | 61 | €698,951 | €651,089 | -€47,863 | -6.8% |
| Remuneration, social security and pensions | 62 | €391,721 | €447,035 | +€55,314 | +14.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €34,969 | €22,898 | -€12,072 | -34.5% |
| Other operating charges | 640/8 | €6,213 | €6,409 | +€196 | +3.2% |
| Non-recurring operating charges | 66A | - | €30,417 | +€30,417 | |
| Operating profit (loss) | 9901 | €914,363 | €775,126 | -€139,237 | -15.2% |
| Financial income | 75/76B | €70,984 | €113,307 | +€42,322 | +59.6% |
| Recurring financial income | 75 | €70,984 | €113,307 | +€42,322 | +59.6% |
| Other financial income | 752/9 | €70,984 | €113,307 | +€42,322 | +59.6% |
| Financial charges | 65/66B | €48,091 | €127,949 | +€79,858 | +166.1% |
| Recurring financial charges | 65 | €48,091 | €127,949 | +€79,858 | +166.1% |
| Other financial charges | 652/9 | €48,091 | €127,949 | +€79,858 | +166.1% |
| Profit (loss) for the period before taxes | 9903 | €937,256 | €760,484 | -€176,773 | -18.9% |
| Income taxes | 67/77 | €252,352 | €198,577 | -€53,775 | -21.3% |
| Taxes | 670/3 | €252,352 | €198,577 | -€53,775 | -21.3% |
| Profit (loss) for the period | 9904 | €684,904 | €561,907 | -€122,997 | -18.0% |
| Profit (loss) for the period to be appropriated | 9905 | €684,904 | €561,907 | -€122,997 | -18.0% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.